We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
C4x Discovery Holdings Plc | LSE:C4XD | London | Ordinary Share | GB00BQQ2RV18 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.00 | 10.30 | 10.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.71M | -11.11M | -0.0441 | -2.72 | 30.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/3/2024 12:44 | I thought this was a sensible LTBH, but far too illiquid for me and will aim to leave when we have one of those rare "spikes".... | takeiteasy | |
20/3/2024 18:10 | Looking like a game of snakes and ladders here atm...gla | itsmespot1 | |
20/3/2024 13:17 | What happened to the 14p it last closed at?. How can they open up at 1p less for no reason. | luckyabbeygale | |
20/3/2024 08:09 | Annoying how this share always opens £700 lower for me. | luckyabbeygale | |
18/3/2024 16:15 | Hope so Davy lad | bloomberg2 | |
18/3/2024 15:49 | This stock is so under valued its unbelievable | tony_penny | |
18/3/2024 15:46 | This stock is so under valued its unbelieable | tony_penny | |
18/3/2024 15:38 | hopefully sanofi are about to part with a few quid | tony_penny | |
18/3/2024 15:35 | interesting rise, news on the way? | davemac3 | |
06/3/2024 17:59 | So little trading activity here I have to pinch myself we are a listed entity. One day we hope things may pick up a little :) | takeiteasy | |
29/2/2024 15:39 | DM3, spot on article - and it reminds me the extra challenges we have being such a niche part of the biotech space which again makes it harder for new investors to resonate with us compared to say drugs for weight loss etc. Duty on the firm to be bold and broaden their networks with senior industry players and market their message around. | takeiteasy | |
23/2/2024 13:38 | A serious seller dumping atm- is this one of the larger holders...we simply do not know and wait on a large holdings note if this applies. There does not seem to me to be much valuation interest in companies who fail to have assets in phases 1-3 etc. I am happy to be corrected but big pharma seem to want ready to go products in the main and will pay up. Clearly we do have AZ in background development mode with our product but this is not whetting investor appetite atm. dyor | takeiteasy | |
23/2/2024 08:50 | Hopefully attract JV partners | the donald | |
23/2/2024 08:30 | They would need stacks of cash to do clinical trials | davemac3 | |
22/2/2024 23:04 | Seems to have worked ok for sln ...that is my only experience ...much better access to long term funding than we did while on AimI do think we need to develop some later stage clinical assets here for everyone to get excited about - it is a shame we sold off an asset recently Do others agree | takeiteasy | |
22/2/2024 21:13 | I know AS is herebut the issues were with DP at 4d | the donald | |
22/2/2024 18:31 | It helped cover up the fraud !! | amaretto1 | |
22/2/2024 18:15 | 4d Pharma spent many, many millions listing on the nasdaq and it made no difference. Waste of money. | the donald | |
22/2/2024 18:07 | It's a terrible reason for listing elsewhere - absolutely dreadful. | nigelpm | |
22/2/2024 17:28 | but if the result is some knowledgeable committed shareholders who are able to make a determination of the true value of a business like ours then it is a price worth paying in my book .... | takeiteasy | |
22/2/2024 17:09 | V expensive to list on Nasdeq | the donald |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions